Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
InhaleRx Limited ( (AU:IRX) ) has provided an announcement.
InhaleRx Limited has announced a proposed issuance of securities, including 4,953,367 unlisted options and 9,906,734 ordinary fully paid shares. This move, set to take place in December 2025, is part of a standard pro rata issue, which is non-renounceable. The issuance aims to bolster the company’s financial standing and potentially enhance its market position by increasing its capital base. This strategic financial maneuver could have significant implications for stakeholders, as it may influence the company’s operational capabilities and competitive edge in the pharmaceutical industry.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on developing and providing inhalation-based therapeutic solutions. The company is involved in the production and distribution of products that leverage inhalation technology for medical purposes.
Average Trading Volume: 257,297
Technical Sentiment Signal: Hold
Current Market Cap: A$7.85M
Learn more about IRX stock on TipRanks’ Stock Analysis page.